The vast majority of pancreatic ductal adenocarcinoma (PDAC) is characterized by the presence of mutant K-ras and is one of the deadliest malignancies with a 5-year survival rate of less than 10% [1,2]. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.